Harteze 10mg 28’s (Rivaroxaban)

Harteze 10mg 28’s (Rivaroxaban) is a highly selective direct factor Xa inhibitor with oral bioavailability. Inhibition of factor Xa interrups the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibiting both thrombin formation and development of thrombi. Rivaroxaban does not inhibit thrombin (active factor III) and no effect on platelets have been demonstrated

KSh1,560.00

Harteze 10mg 28’s (Rivaroxaban)

Description

Harteze 10mg 28’s (Rivaroxaban) is used to treat or prevent blood clots (venous thromboembolism, or VTE). Blood clots can occur in the legs (deep vein thrombosis, DVT) or the lungs (pulmonary embolism, PE).

Blood clots can develop when you are very ill and cannot move around as much as normal, such as during or after a stay in the hospital. Blood clots may also develop after knee or hip replacement surgery.

Rivaroxaban is sometimes used to lower your risk of a blood clot coming back after you have received treatment for blood clots for at least 6 months.

Rivaroxaban is also used in people with atrial fibrillation (a heart rhythm disorder) to lower the risk of stroke caused by a blood clot.

Rivaroxaban is also given together with aspirin to lower the risk of stroke, heart attack, or other serious heart problems in people with coronary artery disease (decreased blood flow to the heart) or peripheral artery disease (decreased blood flow to the legs).

Rivaroxaban may also be used for purposes not listed in this medication guide.